Next Article in Journal
The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes
Next Article in Special Issue
Prevention of Osteoporosis by Oral Administration of Phytate-Removed and Deamidated Soybean β-Conglycinin
Previous Article in Journal
The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo
Previous Article in Special Issue
Lunasin Sensitivity in Non-Small Cell Lung Cancer Cells Is Linked to Suppression of Integrin Signaling and Changes in Histone Acetylation
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2015, 16(1), 256-283; https://doi.org/10.3390/ijms16010256
Action Date Notes Link
article pdf uploaded. 24 December 2014 11:39 CET Version of Record https://www.mdpi.com/1422-0067/16/1/256/pdf
article xml file uploaded 28 January 2015 02:01 CET Original file https://www.mdpi.com/1422-0067/16/1/256/xml
article html file updated 28 January 2015 02:01 CET Original file -
article html file updated 21 August 2015 04:46 CEST Update -
article html file updated 25 March 2019 19:44 CET Update -
article html file updated 7 May 2019 03:25 CEST Update -
article html file updated 6 February 2020 14:43 CET Update https://www.mdpi.com/1422-0067/16/1/256/html
Back to TopTop